Measles

The Lancet

Volumn 379, Issue 9811, 2012, Pages 153-164

  Moss, William J ^a   Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; MATERNAL ANTIBODY; MEASLES VACCINE;

ADAPTIVE IMMUNITY; AFRICA; AMINO ACID SEQUENCE; ARTICLE; COMMON COLD; CONJUNCTIVA; DIARRHEA; DISEASE SEVERITY; DISEASE SURVEILLANCE; EPIDEMIC; EUROPE; EXTRACELLULAR MATRIX; FEVER; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION CONTROL; INNATE IMMUNITY; KERATOCONJUNCTIVITIS; LARYNGOTRACHEOBRONCHITIS; MEASLES; MEASLES VIRUS; MORTALITY; MOUTH ULCER; NONHUMAN; OTITIS MEDIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TERTIARY STRUCTURE; SEX DIFFERENCE; STOMATITIS; STRUCTURE ANALYSIS; SUBACUTE SCLEROSING PANENCEPHALITIS; UNITED STATES; VACCINATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84855843640     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62352-5     Document Type: Review

References (136)

1. FL Black Measles endemicity in insular populations: critical community size and its evolutionary implication J Theor Biol 11 1966 207 211
2. Y Furuse, A Suzuki, H Oshitani Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries Virol J 7 2010 52
3. JF Enders, TC Peebles Propagation in tissue cultures of cytopathic agents from patients with measles Proc Soc Exp Biol Med 86 1954 277 286
4. NJ Gay The theory of measles elimination: implications for the design of elimination strategies J Infect Dis 189 suppl 1 2004 S27 S35
5. VM Caceres, PM Strebel, RW Sutter Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review Clin Infect Dis 31 2000 110 119 (Pubitemid 32268948)
6. E Leuridan, N Hens, V Hutse, M Ieven, M Aerts, P Van Damme Early waning of maternal measles antibodies in era of measles elimination: longitudinal study BMJ 340 2010 c1626
7. M Garenne Sex differences in measles mortality: a world review Int J Epidemiol 23 1994 632 642 (Pubitemid 24214873)
8. RT Perry, NA Halsey The clinical significance of measles: a review J Infect Dis 189 suppl 1 2004 S4 16
9. AC Brown, WJ Moss Sex, pregnancy and measles SL Klein C Roberts Sex hormones and immunity to infection 2010 Springer-Verlag Berlin and Heidelberg, Germany 281 302
10. NA Halsey Increased mortality after high-titre measles vaccines: too much of a good thing Pediatr Infect Dis J 12 1993 462 465 (Pubitemid 23173488)
11. PE Fine, JA Clarkson Measles in England and Wales - I: an analysis of factors underlying seasonal patterns Int J Epidemiol 11 1982 5 14 (Pubitemid 12178852)
12. MJ Ferrari, RF Grais, N Bharti et al. The dynamics of measles in sub-Saharan Africa Nature 451 2008 679 684 (Pubitemid 351220562)
13. WHO World Health Assembly Resolution WHA 52.20. Reducing global measles mortality 2003 World Health Organization Geneva
14. LJ Wolfson, PM Strebel, M Gacic-Dobo, EJ Hoekstra, JW McFarland, BS Hersh Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study Lancet 369 2007 191 200 (Pubitemid 46107682)
15. WHO Global reductions in measles mortality 2000-2008 and the risk of measles resurgence Weekly Epidemiol Rec 84 2009 509 516
16. WHO United Nations Children's Fund Global immunization vision and strategy 2006-2015 2005 World Health Organization Geneva, Switzerland
17. WHO Monitoring progress towards measles elimination Wkly Epidemiol Rec 85 2010 490 495
18. CA de Quadros, JK Andrus, MC Danovaro-Holliday, C Castillo-Solorzano Feasibility of global measles eradication after interruption of transmission in the Americas Expert Rev Vaccines 7 2008 355 362 (Pubitemid 351520023)
19. Centers for Disease Control and Prevention Progress toward measles control - African region, 2001-2008 MMWR Morb Mortal Wkly Rep 58 2009 1036 1041
20. World Health Organization Regional Committee for Africa. Towards the elimination of measles in the African region by 2020. Report of the Regional Director. 2009.
21. M Muscat, H Bang, J Wohlfahrt, S Glismann, K Molbak Measles in Europe: an epidemiological assessment Lancet 373 2009 383 389
22. WHO Outbreak news. Measles outbreaks in Europe Wkly Epidemiol Rec 86 2011 173 174
23. Centers for Disease Control and Prevention (CDC) Measles - United States, January-May 20, 2011 MMWR Morb Mortal Wkly Rep 60 2011 666 668
24. AA Parker, W Staggs, GH Dayan et al. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States N Engl J Med 355 2006 447 455 (Pubitemid 44162272)
25. F Dallaire, G De Serres, FW Tremblay, F Markowski, G Tipples Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons J Infect Dis 200 2009 1602 1605
26. WHO Measles outbreaks and progress towards meeting measles pre-elimination goals: WHO African Region, 2009-2010 Wkly Epidemiol Rec 86 2011 129 136
27. WJ Moss, DE Griffin Global measles elimination Nat Rev Microbiol 4 2006 900 908 (Pubitemid 44768252)
28. E Malvoisin, TF Wild Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins J Gen Virol 74 1993 2365 2372 (Pubitemid 23332297)
29. MO Ota, Z Ndhlovu, S Oh et al. Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination J Infect Dis 195 2007 1799 1807 (Pubitemid 46870253)
30. Y Yanagi, M Takeda, S Ohno Measles virus: cellular receptors, tropism and pathogenesis J Gen Virol 87 2006 2767 2779 (Pubitemid 44463885)
31. A Watanabe, M Yoneda, F Ikeda, Y Terao-Muto, H Sato, C Kai CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells J Virol 84 2010 4183 4193
32. M Kuhne, DW Brown, L Jin Genetic variability of measles virus in acute and persistent infections Infect Genet Evol 6 2006 269 276
33. T Hashiguchi, M Kajikawa, N Maita et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines Proc Natl Acad Sci USA 104 2007 19535 19540
34. SA Frank, RM Bush Barriers to antigenic escape by pathogens: trade-off between reproductive rate and antigenic mutability BMC Evol Biol 7 2007 229
35. RT Chen, GM Goldbaum, SG Wassilak, LE Markowitz, WA Orenstein An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease Am J Epidemiol 129 1989 173 182 (Pubitemid 19030710)
36. J Lessler, NG Reich, R Brookmeyer, TM Perl, KE Nelson, DA Cummings Incubation periods of acute respiratory viral infections: a systematic review Lancet Infect Dis 9 2009 291 300
37. MA Riddell, WJ Moss, D Hauer, M Monze, DE Griffin Slow clearance of measles virus RNA after acute infection J Clin Virol 39 2007 312 317 (Pubitemid 47069037)
38. SR Permar, WJ Moss, JJ Ryon et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction J Infect Dis 183 2001 532 538 (Pubitemid 32147508)
39. DE Griffin Measles virus-induced suppression of immune responses Immunol Rev 236 2010 176 189
40. RL de Swart, M Ludlow, L de Witte et al. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques PLoS Pathog 3 2007 e178
41. VH Leonard, PL Sinn, G Hodge et al. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed J Clin Invest 118 2008 2448 2458 (Pubitemid 351949773)
42. M Takeda Measles virus breaks through epithelial cell barriers to achieve transmission J Clin Invest 118 2008 2386 2389 (Pubitemid 351949767)
43. WJ Moss, F Cutts, DE Griffin Implications of the human immunodeficiency virus epidemic for control and eradication of measles Clin Infect Dis 29 1999 106 112 (Pubitemid 29336811)
44. B Hahm Hostile communication of measles virus with host innate immunity and dendritic cells Curr Top Microbiol Immunol 330 2009 271 287
45. D Naniche Human immunology of measles virus infection Curr Top Microbiol Immunol 330 2009 151 171
46. FL Black, H Yannet Inapparent measles after gamma globulin administration JAMA 173 1960 1183 1188
47. RA Good, SJ Zak Disturbances in gamma globulin synthesis as "experiments of nature" Pediatrics 18 1956 109 149
48. WJ Moss, JJ Ryon, M Monze, DE Griffin Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children J Infect Dis 186 2002 879 887
49. CH Pan, CE Greer, D Hauer et al. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles J Virol 84 2010 3798 3807
50. SM Akramuzzaman, FT Cutts, JG Wheeler, MJ Hossain Increased childhood morbidity after measles is short-term in urban Bangladesh Am J Epidemiol 151 2000 723 735 (Pubitemid 30463594)
51. VG Tamashiro, HH Perez, DE Griffin Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles Pediatr Infect Dis J 6 1987 451 454 (Pubitemid 17072087)
52. HM Coovadia, A Wesley, LG Henderson, P Brain, GH Vos, AF Hallett Alterations in immune responsiveness in acute measles and chronic post-measles chest disease Int Arch Allergy Appl Immunol 56 1978 14 23
53. AP Beckford, RO Kaschula, C Stephen Factors associated with fatal cases of measles: a retrospective autopsy study S Afr Med J 68 1985 858 863 (Pubitemid 16177108)
54. BL Greenberg, RB Sack, E Salazar-Lindo et al. Measles-associated diarrhea in hospitalized children in Lima, Peru: pathogenic agents and impact on growth J Infect Dis 163 1991 495 502
55. C von Pirquet Das Verhalten der kutanen Tuberkulin-Reaktion warend der Masern Deut Med Wochenschr 34 1908 1297 1300
56. E Avota, E Gassert, S Schneider-Schaulies Measles virus-induced immunosuppression: from effectors to mechanisms Med Microbiol Immunol 199 2010 227 237
57. JJ Ryon, WJ Moss, M Monze, DE Griffin Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles Clin Diagn Lab Immunol 9 2002 994 1003 (Pubitemid 34988465)
58. RL Hirsch, DE Griffin, RT Johnson et al. Cellular immune responses during complicated and uncomplicated measles virus infections of man Clin Immunol Immunopathol 31 1984 1 12 (Pubitemid 14168274)
59. C Servet-Delprat, PO Vidalain, O Azocar, F Le Deist, A Fischer, C Rabourdin-Combe Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus J Virol 74 2000 4387 4393 (Pubitemid 30214446)
60. DE Griffin, SJ Cooper, RL Hirsch et al. Changes in plasma IgE levels during complicated and uncomplicated measles virus infections J Allergy Clin Immunol 76 1985 206 213 (Pubitemid 15003561)
61. DE Griffin, BJ Ward Differential CD4 T cell activation in measles J Infect Dis 168 1993 275 281 (Pubitemid 23210599)
62. XL Yu, YM Cheng, BS Shi et al. Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+ CD25+ regulatory T cells J Immunol 181 2008 7356 7366
63. LM Tierney Jr, KC Wang Images in clinical medicine. Koplik's spots N Engl J Med 354 2006 740
64. D Morley Severe measles in the tropics BMJ 1 1969 297 300
65. LJ Wolfson, RF Grais, FJ Luquero, ME Birmingham, PM Strebel Estimates of measles case fatality ratios: a comprehensive review of community-based studies Int J Epidemiol 38 2009 192 205
66. T Duke, CS Mgone Measles: not just another viral exanthem Lancet 361 2003 763 773 (Pubitemid 36293634)
67. TM Moussallem, F Guedes, ER Fernandes et al. Lung involvement in childhood measles: severe immune dysfunction revealed by quantitative immunohistochemistry Hum Pathol 38 2007 1239 1247 (Pubitemid 47058162)
68. RD Semba, MW Bloem Measles blindness Surv Ophthalmol 49 2004 243 255 (Pubitemid 38304875)
69. RT Johnson, DE Griffin, RL Hirsch et al. Measles encephalomyelitis - clinical and immunologic studies N Engl J Med 310 1984 137 141 (Pubitemid 14224106)
70. A Turner, D Jeyaratnam, F Haworth et al. Measles-associated encephalopathy in children with renal transplants Am J Transplant 6 2006 1459 1465 (Pubitemid 44030330)
71. AF Freeman, DA Jacobsohn, ST Shulman et al. A new complication of stem cell transplantation: measles inclusion body encephalitis Pediatrics 114 2004 e657 e660
72. WJ Bellini, JS Rota, LE Lowe et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized J Infect Dis 192 2005 1686 1693 (Pubitemid 41587817)
73. H Campbell, N Andrews, KE Brown, E Miller Review of the effect of measles vaccination on the epidemiology of SSPE Int J Epidemiol 36 2007 1334 1348 (Pubitemid 350239003)
74. TM Marshall, D Hlatswayo, B Schoub Nosocomial outbreaks - a potential threat to the elimination of measles? J Infect Dis 187 suppl 1 2003 S97 101
75. V Dietz, J Rota, H Izurieta, P Carrasco, W Bellini The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas Bull World Health Organ 82 2004 852 857 (Pubitemid 39573743)
76. Department of Vaccines and Biologicals WHO WHO-recommended standards of surveillance of selected vaccine-preventable diseases 2003 World Health Organization Geneva
77. WJ Bellini, RF Helfand The challenges and strategies for laboratory diagnosis of measles in an international setting J Infect Dis 187 suppl 1 2003 S283 S290
78. RF Helfand, S Kebede, S Mercader, HE Gary Jr, H Beyene, WJ Bellini The effect of timing of sample collection on the detection of measles-specific IgM in serum and oral fluid samples after primary measles vaccination Epidemiol Infect 123 1999 451 456
79. WHO Recommendations from an ad hoc meeting of the WHO Measles and Rubella Laboratory Network (LabNet) on the use of alternative diagnostic samples for measles and rubella surveillance MMWR Morb Mortal Wkly Rep 57 2008 657 660
80. L Warrener, R Slibinskas, D Brown, K Sasnauskas, D Samuel Development and evaluation of a rapid immunochromatographic test for mumps-specific IgM in oral fluid specimens and use as a matrix for preserving viral nucleic acid for RT-PCR J Med Virol 82 2010 485 493
81. PA Rota, DA Featherstone, WJ Bellini Molecular epidemiology of measles virus Curr Top Microbiol Immunol 330 2009 129 150
82. Y Zhang, Z Ding, H Wang et al. New measles virus genotype associated with outbreak, China Emerg Infect Dis 16 2010 943 947
83. Y Huiming, W Chaomin, M Meng Vitamin A for treating measles in children Cochrane Database Syst Rev 4 2005 CD001479
84. WHO Strategies for reducing global measles mortality Wkly Epidemiol Rec 75 2000 411 416
85. D Reuter, J Schneider-Schaulies Measles virus infection of the CNS: human disease, animal models, and approaches to therapy Med Microbiol Immunol 199 2010 261 271
86. SK Kabra, R Lodha, DJ Hilton Antibiotics for preventing complications in children with measles Cochrane Database Syst Rev 3 2008 CD001477
87. WHO Measles vaccines Wkly Epidemiol Rec 84 2009 349 360
88. DE Griffin, MB Oldstone Measles. History and basic biology. Introduction Curr Top Microbiol Immunol 329 2009 1
89. CL Parks, RA Lerch, P Walpita, HP Wang, MS Sidhu, SA Udem Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage J Virol 75 2001 910 920 (Pubitemid 32037293)
90. C Condack, JC Grivel, P Devaux, L Margolis, R Cattaneo Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration J Infect Dis 196 2007 541 549 (Pubitemid 47206100)
91. NA Halsey The optimal age for administering measles vaccine in developing countries NA Halsey CA de Quadros Recent advances in immunization: a bibliographic review 1983 Pan American Health Organization Washington, DC 4 17
92. WJ Moss, S Scott WHO immunological basis for immunization series: measles 2009 World Health Organization Geneva, Switzerland
93. CA de Quadros, JM Olive, BS Hersh et al. Measles elimination in the Americas: evolving strategies JAMA 275 1996 224 229
94. IJ Amanna, NE Carlson, MK Slifka Duration of humoral immunity to common viral and vaccine antigens N Engl J Med 357 2007 1903 1915 (Pubitemid 350074686)
95. JR Kremer, F Schneider, CP Muller Waning antibodies in measles and rubella vaccinees - a longitudinal study Vaccine 24 2006 2594 2601 (Pubitemid 43290391)
96. E Mantadakis, E Farmaki, GR Buchanan Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management J Pediatr 156 2010 623 628
97. AJ Wakefield, SH Murch, A Anthony et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 351 1998 637 641 (Pubitemid 28098447)
98. VA Jansen, N Stollenwerk, HJ Jensen, ME Ramsay, WJ Edmunds, CJ Rhodes Measles outbreaks in a population with declining vaccine uptake Science 301 2003 804 (Pubitemid 36962614)
99. PA Offit, SE Coffin Communicating science to the public: MMR vaccine and autism Vaccine 22 2003 1 6 (Pubitemid 37357146)
100. KM Madsen, A Hviid, M Vestergaard et al. A population-based study of measles, mumps, and rubella vaccination and autism N Engl J Med 347 2002 1477 1482 (Pubitemid 35257586)
101. F DeStefano Vaccines and autism: evidence does not support a causal association Clin Pharmacol Ther 82 2007 756 759
102. Retraction - Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children Lancet 375 2010 445
103. DE Griffin, CH Pan, WJ Moss Measles vaccines Front Biosci 13 2008 1352 1370 (Pubitemid 351606114)
104. VA Fulginiti, JJ Eller, AW Downie, CH Kempe Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccines JAMA 202 1967 1075
105. M Garenne, O Leroy, JP Beau, I Sene Child mortality after high-titre measles vaccines: prospective study in Senegal Lancet 338 1991 903 907
106. FP Polack, SH Lee, S Permar et al. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles Nat Med 6 2000 776 781 (Pubitemid 30469426)
107. M Premenko-Lanier, PA Rota, G Rhodes et al. DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate Virology 307 2003 67 75 (Pubitemid 36349437)
108. M Premenko-Lanier, PA Rota, GH Rhodes, WJ Bellini, MB McChesney Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody J Infect Dis 189 2004 2064 2071 (Pubitemid 38692287)
109. MH Skiadopoulos, SR Surman, JM Riggs, PL Collins, BR Murphy A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys J Virol 75 2001 10498 10504 (Pubitemid 32948082)
110. MF Pasetti, EM Barry, G Losonsky et al. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats J Virol 77 2003 5209 5217 (Pubitemid 36460935)
111. DE Webster, MC Thomas, Z Huang, SL Wesselingh The development of a plant-based vaccine for measles Vaccine 23 2005 1859 1865 (Pubitemid 40331859)
112. WH Lin, DE Griffin, PA Rota et al. Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques Proc Natl Acad Sci USA 108 2011 2987 2992
113. A Dilraj, FT Cutts, JF de Castro et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial Lancet 355 2000 798 803 (Pubitemid 30128820)
114. JV Bennett, J Fernandez de Castro, JL Valdespino-Gomez et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren Bull World Health Organ 80 2002 806 812 (Pubitemid 35246731)
115. RM Wong-Chew, R Islas-Romero, L Garcia-Garcia Mde et al. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children Vaccine 24 2006 683 690 (Pubitemid 43017835)
116. RM Wong-Chew, R Islas-Romero, L Garcia-Garcia Mde et al. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children J Infect Dis 189 2004 254 257 (Pubitemid 38147249)
117. N Low, S Kraemer, M Schneider, AM Restrepo Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis Vaccine 26 2008 383 398
118. DJ Sencer, HB Dull, AD Langmuir Epidemiologic basis for eradication of measles in 1967 Public Health Rep 82 1967 253 256
119. The eradication of infectious diseases: report of the Dahlem Workshop on the eradication of infectious diseases, Berlin, March 16-22, 1997 1998 John Wiley and Sons New York
120. K Glass, K Kappey, BT Grenfell The effect of heterogeneity in measles vaccination on population immunity Epidemiol Infect 132 2004 675 683 (Pubitemid 39140099)
121. WA Orenstein, PM Strebel, M Papania, RW Sutter, WJ Bellini, SL Cochi Measles eradication: is it in our future? Am J Public Health 90 2000 1521 1525
122. RK Garg Subacute sclerosing panencephalitis J Neurol 255 2008 1861 1871
123. A Tamin, PA Rota, ZD Wang, JL Heath, LJ Anderson, WJ Bellini Antigenic analysis of current wild type and vaccine strains of measles virus J Infect Dis 170 1994 795 801 (Pubitemid 24296554)
124. J Mossong, DJ Nokes, WJ Edmunds, MJ Cox, S Ratnam, CP Muller Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity Am J Epidemiol 150 1999 1238 1249
125. FA Lievano, MJ Papania, RF Helfand et al. Lack of evidence of measles virus shedding in people with inapparent measles virus infections J Infect Dis 189 suppl 1 2004 S165 S170
126. WJ Moss, M Monze, JJ Ryon, TC Quinn, DE Griffin, F Cutts Prospective study of measles in hospitalized human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia Clin Infect Dis 35 2002 189 196 (Pubitemid 34753905)
127. S Scott, WJ Moss, S Cousens et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants Clin Infect Dis 45 2007 1417 1424 (Pubitemid 351411869)
128. WJ Moss, S Scott, N Mugala et al. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study J Infect Dis 196 2007 347 355 (Pubitemid 47093884)
129. MC Tejiokem, I Gouandjika, L Beniguel et al. HIV-infected children living in central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization PLoS One 2 2007 e1260
130. ML McMorrow, G Gebremedhin, J van den Heever et al. Measles outbreak in South Africa, 2003-2005 S Afr Med J 99 2009 314 319
131. RF Helfand, WJ Moss, R Harpaz, S Scott, F Cutts Evaluating the impact of the HIV pandemic on measles control and elimination Bull World Health Organ 83 2005 329 337 (Pubitemid 40704861)
132. M Otten, R Kezaala, A Fall et al. Public-health impact of accelerated measles control in the WHO African Region 2000-03 Lancet 366 2005 832 839 (Pubitemid 41557383)
133. CG Sutcliffe, WJ Moss Do HIV-infected children receiving HAART need to be revaccinated? a review of the literature Lancet Infect Dis 10 2010 630 642
134. S Scott, J Mossong, WJ Moss, FT Cutts, S Cousens Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model Int J Epidemiol 37 2008 356 367 (Pubitemid 351505889)
135. L Aurpibul, T Puthanakit, T Sirisanthana, V Sirisanthana Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy Clin Infect Dis 50 2010 1415 1418
136. RE Black, S Cousens, HL Johnson et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis Lancet 375 2010 1969 1987